| |
| |
|
| Insider
Information: |
Azoy Alexander |
| Relationship: |
Chief Accounting Officer |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
257,622 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$501,914 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
257,622 |
|
|
| Total
Value |
$501,914 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sienna Biopharmaceuticals, Inc. |
SNNA |
|
2019-10-02 |
103,552 |
2019-04-01 |
0 |
Premium* |
|
|
Unity Biotechnology Inc |
UBX |
See Remarks |
2020-09-13 |
135,000 |
2020-09-13 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Chief Accounting Officer |
2024-01-23 |
19,070 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,850 |
19,070 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2023-12-20 |
4 |
D |
$18.21 |
$1,238 |
D/D |
(68) |
10,220 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2023-12-19 |
4 |
D |
$18.09 |
$11,957 |
D/D |
(661) |
10,288 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2023-12-18 |
4 |
D |
$17.74 |
$11,478 |
D/D |
(647) |
10,949 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2023-12-01 |
4 |
AS |
$14.95 |
$4,216 |
D/D |
(282) |
11,596 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting Officer |
• – – |
2023-07-03 |
4 |
AS |
$20.41 |
$20,777 |
D/D |
(1,018) |
11,596 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Chief Accounting OfficerOffice |
• – – |
2023-03-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,596 |
|
% |
|
| UBX |
Unity Biotechnology Inc |
See Remarks |
• – – |
2020-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
135,000 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
• – – |
2019-10-02 |
4 |
D |
$0.23 |
$551 |
D/D |
(2,396) |
103,552 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
• – – |
2019-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
105,948 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
• – – |
2019-07-02 |
4 |
D |
$0.76 |
$1,180 |
D/D |
(1,552) |
35,948 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
• – – |
2019-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,500 |
|
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
• – – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,500 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
